Ligne 5 : |
Ligne 5 : |
| | | |
| == Biographie du Dr Mayne par lui-même == | | == Biographie du Dr Mayne par lui-même == |
| + | Dr Peter Mayne MBBS (Sydney) DPD (Cardiff) IDD (Graz) FACRRM |
| + | |
| + | Le Dr Peter Mayne est professeur associé honoraire au Département de médecine de l'Université de Cardiff (dermatologie) et membre actif de l'[[ILADS]] (International Lyme and Associated Diseases Society). Il a également suivi une formation médicale sur la [[maladie de Lyme]] aux Etats-Unis. |
| + | |
| + | Le Dr Mayne est un médecin généraliste rural qui traite la [[maladie de Lyme]] depuis plus de 22 ans dans son cabinet actuel à Laurieton NSW, juste au nord de Newcastle, en Australie. Depuis 1991, pendant quelques années, des chercheurs de l'Université de Newcastle proposaient la détection par PCR de la [[maladie de Lyme]] à partir de tiques, et à partir de ce moment, il a trouvé de nombreux patients atteints d'une infection confirmée de la [[maladie de Lyme]]. Le Dr Mayne a été le premier à identifier la mouche de mars [en anglais: march fly] (mouche du cheval) comme un autre vecteur en Australie. En 2004, il a suivi une formation en dermatologie puis en dermoscopie. Son intérêt pour les manifestations dermatologiques à long terme de la [[maladie de Lyme]] s'est accru. En 2009, il s'est impliqué dans les tests de sensibilité clinique de la détection par PCR de la [[maladie de Lyme]] chez Australian Biologics avec analyse de ses patients pour tester les amorces. Il a ensuite pu à nouveau avoir accès à la détection par PCR de la [[maladie de Lyme]] et, à partir de là, il a trouvé des patients atteints de la [[maladie de Lyme chronique]]. Il reçoit maintenant des références de toute l'Australie, de la Nouvelle-Zélande et de l'Asie du Sud-Est. La [[maladie de Lyme]] constitue maintenant une composante considérable de sa pratique. |
| + | |
| + | Le Dr Mayne croit que la [[maladie de Lyme]] n'est pas seulement la [[maladie de Lyme]], il existe d'autres coinfections nées de tiques. En Australie, il s'agit de Bartonella, Babesia microtii, Babesia duncanii et d'une série d'infections rickettsi dont trois sont uniques à l'Australie. En collaboration avec un autre collègue australien, il existe maintenant des preuves de différentes souches cliniques de Babesia et de Bartonella sur ce continent. Bien que toutes ces maladies puissent être transmises par les tiques, les puces sont connues pour être des vecteurs de la Bartonella. D'autres arthropodes vecteurs seront sans doute identifiés dans ces maladies, car il s'agit d'un domaine en pleine explosion de la science médicale en Australie pour le moment. En plus des coinfections standard, ces patients fourniront toujours des preuves d'autres infections virales, bactériennes et fongiques. Les plus frappantes sont Mycoplasma, y compris les fermentans et Chlamydia pneumoniae. Le Dr Mayne traite toutes ces infections de manière appropriée et utilise les directives [guidelines] [[ILADS]] pour le traitement de Lyme. |
| + | |
| + | Il y a beaucoup de patients qui ont été vus dans sa pratique avec des diagnostics de Parkinson, de sclérose en plaques, de neurone moteur et de SLA<ref>https://fr.wikipedia.org/wiki/Scl%C3%A9rose_lat%C3%A9rale_amyotrophique</ref> où une évaluation approfondie a mené à la preuve en laboratoire de la [[maladie de Lyme]]. Ces scénarios n'ont cependant pas été faciles à traiter en raison de la nature avancée de la maladie à l'étude. |
| + | |
| + | Le Dr Mayne publie activement des données sur ses travaux de Lyme à partir de décembre 2011 avec Emerging Incidence of Lyme borreliosis, babesiosis, bartonellosis and granulocytic ehrlichiosis en Australie. Comme son titre l'indique, cet article commence à explorer l'incidence de la lyme et de ces coinfections en Australie. Il s'agit du premier ouvrage publié sur le sujet clinique depuis environ 18 ans. Elle a été suivie d'une étude des génotypes de Borrelia burgdorferi en Australie, obtenus à partir de tissus érythémateux migrateurs, qui prouve l'existence de la [[maladie de Lyme]] en Australie et amorce le processus d'identification des génotypes locaux du lyme. Il a d'autres recherches sont à paraître dans un proche avenir. |
| + | |
| + | La [[maladie des Morgellons]] est une dermopathie cutanée spirochaétale connue pour être étroitement associée à la [[maladie de Lyme]]. D'importantes recherches ont été publiées à ce sujet à la fin de 2011 et en 2012. La Fondation Charles Holman est la seule organisation qui s'intéresse officiellement à l'avancement des connaissances sur cette maladie. Le Dr Mayne siège au conseil scientifique de l'organisation et a présenté un exposé sur les caractéristiques dermatologiques et le diagnostic différentiel de la maladie lors de la dernière conférence annuelle à Austin. C'est l'objet du présent document de recherche qu'il rédige encore aujourd'hui. Ce document vise à éliminer le concept de délire parasitaire de la terminologie médicale et à éliminer le stigmate social de la maladie, en particulier chez les enfants. |
| + | |
| + | Le Dr Mayne évalue et traite les enfants qui ont reçu un mauvais diagnostic de TDA, de TDAH, d'autisme et d'Aspberg pour la [[maladie de Lyme]] et les coinfections associées. Il raconte la joie de voir l'amélioration chez les enfants atteints de Lyme. |
| + | |
| + | Pour télécharger gratuitement en format PDF les publications du Dr Mayne, cliquez sur les liens ci-dessous pour accéder à Dove Press : |
| + | |
| + | Télécharger : Emerging Incidence of Lyme borreliosis, babesiosis, bartonellosis and granulocytic ehrlichiosis in Australia. |
| + | |
| + | Télécharger : Etude des génotypes de Borrelia burgdorferi en Australie obtenus à partir de tissus érythémateux migrans. |
| + | |
| + | Traduit avec www.DeepL.com/Translator |
| <ref>https://beyondthebandaid.com.au/dr-peter-mayne-mbbs-sydney-dpd-cardiff-idd-graz-facrrm/ Dr Peter Mayne MBBS (Sydney) DPD (Cardiff) IDD (Graz) FACRRM<br>Dr Peter Mayne is a Honorary teaching associate Cardiff University Department of Medicine (Dermatology) and he is also an active member of [[ILADS]] (International Lyme and Associated Diseases Society) and has undergone physician training in Lyme disease in the USA.<br>Dr Mayne is a rural general practitioner who has been treating Lyme disease for over 22 years in his current practice setting at Laurieton NSW just north of Newcastle, Australia. From 1991 for a few years Newcastle University researchers were offering PCR detection of Lyme disease from ticks, and from that time he found many patients with proven Lyme disease infection. Dr Mayne was the first to identify the march fly (horse fly) as another vector in Australia. In 2004 he underwent training in dermatology and later dermoscopy. His interest in the long term dermatological manifestations of Lyme disease was sharpened. In 2009 he became involved in the testing of the clinical sensitivity of PCR detection of Lyme disease at Australian Biologics with analysis of his patients to test the primers. He was then able to access PCR detection of Lyme disease again and from that he found patients with chronic Lyme disease. He now takes referrals from all over Australia, New Zealand and South East Asia. Lyme disease now forms a considerable component of his practice.<br><br>Dr Mayne believes Lyme disease is not just Lyme disease, there are other tick born coinfections. In Australia these are Bartonella, Babesia microtii, Babesia duncanii and a range of the rickettsial infections three of which are unique to Australia. In collaboration with another Australian colleague there is now evidence of different clinical strains of both Babesia and Bartonella on this continent. Whilst all of these can be transmitted by ticks, fleas are known to vector Bartonella. Other arthropod vectors will undoubtedly be identified in these diseases as this is an exploding area of medical science in Australia at the moment. As well as the standard coinfections these patients will always provide evidence of other viral, bacterial and fungal infection. The striking ones are Mycoplasma including fermentans and Chlamydia pneumoniae. Dr Mayne deals with all these infections appropriately and uses ILADS guidelines for Lyme treatment.<br><br>There are many patients that have been seen in his practice with diagnoses of Parkinsons, Multiple Sclerosis, Motor neurone disease and ALS where a thorough assessment has led to laboratory proof of Lyme disease. These scenarios have not been easy to treat though because of the advanced nature of the disease at presentation.<br><br>Dr Mayne is actively publishing data on his Lyme work starting in December 2011 with Emerging Incidence of Lyme borreliosis, babesiosis, bartonellosis and granulocytic ehrlichiosis in Australia. This paper as the title suggests starts to explore the incidence of lyme and those coinfections in Australia. It is the first published work on the clinical subject here for some 18 years. It has been followed by Investigation of Borrelia burgdorferi genotypes in Australia obtained from erythema migrans tissue which further proves the existence of lyme disease in Australia and commences the process of identification of local lyme genotypes. He has more research is to be published in the near future.<br><br>Morgellons disease is a spirochaetal skin dermopathy known to be closely associated with Lyme disease. Considerable important research has been published on this matter in late 2011 and in 2012. The Charles Holman Foundation serves as the only current organisation formally interested in advancing knowledge of the disorder. Dr Mayne serves on the scientific board of the organisation and presented a talk at the last annual conference in Austin on the dermatological features and differential diagnosis of the disorder. This is the subject of his current research paper still in production. This paper will be aimed at removing the concept of delusions of parasitosis from medical terminology, and removing the social stigma of the disease particularly when children are involved.<br><br>Dr Mayne assesses and treats children who have been misdiagnosed with ADD, ADHD, Autism and Aspbergers for Lyme disease and associated coinfections. He relates the joy at seeing the improvement in children with Lyme.<br><br>To access a free PDF download on Dr Mayne’s publications click on the below links to Dove Press:<br><br>Download: Emerging Incidence of Lyme borreliosis, babesiosis, bartonellosis and granulocytic ehrlichiosis in Australia.<br><br>Download: Investigation of Borrelia burgdorferi genotypes in Australia obtained from erythema migrans tissue.</ref> | | <ref>https://beyondthebandaid.com.au/dr-peter-mayne-mbbs-sydney-dpd-cardiff-idd-graz-facrrm/ Dr Peter Mayne MBBS (Sydney) DPD (Cardiff) IDD (Graz) FACRRM<br>Dr Peter Mayne is a Honorary teaching associate Cardiff University Department of Medicine (Dermatology) and he is also an active member of [[ILADS]] (International Lyme and Associated Diseases Society) and has undergone physician training in Lyme disease in the USA.<br>Dr Mayne is a rural general practitioner who has been treating Lyme disease for over 22 years in his current practice setting at Laurieton NSW just north of Newcastle, Australia. From 1991 for a few years Newcastle University researchers were offering PCR detection of Lyme disease from ticks, and from that time he found many patients with proven Lyme disease infection. Dr Mayne was the first to identify the march fly (horse fly) as another vector in Australia. In 2004 he underwent training in dermatology and later dermoscopy. His interest in the long term dermatological manifestations of Lyme disease was sharpened. In 2009 he became involved in the testing of the clinical sensitivity of PCR detection of Lyme disease at Australian Biologics with analysis of his patients to test the primers. He was then able to access PCR detection of Lyme disease again and from that he found patients with chronic Lyme disease. He now takes referrals from all over Australia, New Zealand and South East Asia. Lyme disease now forms a considerable component of his practice.<br><br>Dr Mayne believes Lyme disease is not just Lyme disease, there are other tick born coinfections. In Australia these are Bartonella, Babesia microtii, Babesia duncanii and a range of the rickettsial infections three of which are unique to Australia. In collaboration with another Australian colleague there is now evidence of different clinical strains of both Babesia and Bartonella on this continent. Whilst all of these can be transmitted by ticks, fleas are known to vector Bartonella. Other arthropod vectors will undoubtedly be identified in these diseases as this is an exploding area of medical science in Australia at the moment. As well as the standard coinfections these patients will always provide evidence of other viral, bacterial and fungal infection. The striking ones are Mycoplasma including fermentans and Chlamydia pneumoniae. Dr Mayne deals with all these infections appropriately and uses ILADS guidelines for Lyme treatment.<br><br>There are many patients that have been seen in his practice with diagnoses of Parkinsons, Multiple Sclerosis, Motor neurone disease and ALS where a thorough assessment has led to laboratory proof of Lyme disease. These scenarios have not been easy to treat though because of the advanced nature of the disease at presentation.<br><br>Dr Mayne is actively publishing data on his Lyme work starting in December 2011 with Emerging Incidence of Lyme borreliosis, babesiosis, bartonellosis and granulocytic ehrlichiosis in Australia. This paper as the title suggests starts to explore the incidence of lyme and those coinfections in Australia. It is the first published work on the clinical subject here for some 18 years. It has been followed by Investigation of Borrelia burgdorferi genotypes in Australia obtained from erythema migrans tissue which further proves the existence of lyme disease in Australia and commences the process of identification of local lyme genotypes. He has more research is to be published in the near future.<br><br>Morgellons disease is a spirochaetal skin dermopathy known to be closely associated with Lyme disease. Considerable important research has been published on this matter in late 2011 and in 2012. The Charles Holman Foundation serves as the only current organisation formally interested in advancing knowledge of the disorder. Dr Mayne serves on the scientific board of the organisation and presented a talk at the last annual conference in Austin on the dermatological features and differential diagnosis of the disorder. This is the subject of his current research paper still in production. This paper will be aimed at removing the concept of delusions of parasitosis from medical terminology, and removing the social stigma of the disease particularly when children are involved.<br><br>Dr Mayne assesses and treats children who have been misdiagnosed with ADD, ADHD, Autism and Aspbergers for Lyme disease and associated coinfections. He relates the joy at seeing the improvement in children with Lyme.<br><br>To access a free PDF download on Dr Mayne’s publications click on the below links to Dove Press:<br><br>Download: Emerging Incidence of Lyme borreliosis, babesiosis, bartonellosis and granulocytic ehrlichiosis in Australia.<br><br>Download: Investigation of Borrelia burgdorferi genotypes in Australia obtained from erythema migrans tissue.</ref> |
| | | |